November 27, 2019

B. Sonny Bal, M.D.
President and Chief Executive Officer
Sintx Technologies, Inc.
1885 West 2100 South
Salt Lake City, UT 84119

       Re: Sintx Technologies, Inc.
           Registration Statement on Form S-1
           Filed November 1, 2019
           File No. 333-234438

Dear Dr. Bal:

       We have limited our review of your registration statement to those
issues we have
addressed in our comments. In some of our comments, we may ask you to provide
us with
information so we may better understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comments apply to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to these comments, we may have additional comments.

Registration Statement on Form S-1 filed November 1, 2019

Cover page

1.     We note your disclosure that you may extend the rights offering in your
sole discretion.
       Please revise your disclosure to state a termination date that is not
indefinite. Refer to Item
       501(b)(8)(iii) of Regulation S-K.
The Rights Offering
No Revocation or Change, page 25

2.     We note your disclosure that all exercises of subscription rights are
irrevocable even if
       purchasers learn information about you that purchasers consider to be
unfavorable. Please
       tell us the circumstances under which you will provide your shareholders
with the right to
       revoke subscriptions in the event of material developments during the
offering period.
 B. Sonny Bal, M.D.
Sintx Technologies, Inc.
November 27, 2019
Page 2



        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Joe McCann at 202-551-6262 or Christine Westbrook at
202-551-5019
with any questions.



                                                           Sincerely,
FirstName LastNameB. Sonny Bal, M.D.
                                                           Division of
Corporation Finance
Comapany NameSintx Technologies, Inc.
                                                           Office of Life
Sciences
November 27, 2019 Page 2
cc:       David F. Marx, Esq.
FirstName LastName